Citation, commencement and extent

1. —(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (No. 3) (England, Wales and Scotland) Order 2014 and comes into force on 7th January 2015.

(2) This Order extends to England and Wales and Scotland.

Amendment to the Misuse of Drugs (Designation) Order 2001

2. —(1)The Misuse of Drugs (Designation) Order 2001( 2 ) is amended as follows.

(2) In paragraph 1(a) of Part 1 of the Schedule—

(a) after “Tenocyclidine” insert—

“ (6a R ,9 R )-4-acetyl- N , N -diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide (ALD-52) ” ;

(b) after “4-Bromo-2,5-dimethoxy- a -methylphenethylamine” insert—

“ 3,4-dichloro- N -[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)

(6a R, 9 R )- N,N- diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide (AL-LAD)

(6a R, 9 R ) -N,N- diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3 -fg ]quinoline-9-carboxamide (ETH-LAD)

(6a R, 9 R )- N,N- diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinoline-9-carboxamide (PRO-LAD) ” ;

(c) after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert—

“ 2,4-dimethylazetidinyl{(6a R, 9 R )-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg ]quinolin-9-yl}methanone (LSZ) ” .

(3) For paragraph 1(b) of Part 1 of the Schedule, substitute—

“ (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say—

(i) by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;

(ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;

(iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;

(iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; ” .